Cargando…
A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival
BACKGROUND: Malignant pleural mesothelioma (MPM) is one of the most aggressive tumors with few effective treatments worldwide. It has been suggested that alternative splicing at the transcriptome level plays an indispensable role in MPM. METHODS: We analyzed the splicing profile of 84 MPM patients f...
Autores principales: | Shao, Ming‐Ming, Qiao, Xin, Chen, Qing‐Yu, Yi, Feng‐Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376167/ https://www.ncbi.nlm.nih.gov/pubmed/35790883 http://dx.doi.org/10.1111/1759-7714.14564 |
Ejemplares similares
-
Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022) -
Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009) -
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma
por: Lee, Hyun-Sung, et al.
Publicado: (2018) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009) -
SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)